These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35778330)

  • 41. Receptor targeting of adeno-associated virus vectors.
    Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
    Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AAV capsid design: A Goldilocks challenge.
    Zolotukhin S; Vandenberghe LH
    Trends Mol Med; 2022 Mar; 28(3):183-193. PubMed ID: 35093287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adeno-associated virus serotypes: vector toolkit for human gene therapy.
    Wu Z; Asokan A; Samulski RJ
    Mol Ther; 2006 Sep; 14(3):316-27. PubMed ID: 16824801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel Lung Tropic Adeno-Associated Virus Capsids for Therapeutic Gene Delivery.
    Carneiro A; Lee H; Lin L; van Haasteren J; Schaffer DV
    Hum Gene Ther; 2020 Sep; 31(17-18):996-1009. PubMed ID: 32799685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo.
    Sen D; Gadkari RA; Sudha G; Gabriel N; Kumar YS; Selot R; Samuel R; Rajalingam S; Ramya V; Nair SC; Srinivasan N; Srivastava A; Jayandharan GR
    Hum Gene Ther Methods; 2013 Apr; 24(2):104-16. PubMed ID: 23442071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AAV-mediated liver-directed gene therapy.
    Sands MS
    Methods Mol Biol; 2011; 807():141-57. PubMed ID: 22034029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tailoring the AAV vector capsid for gene therapy.
    Vandenberghe LH; Wilson JM; Gao G
    Gene Ther; 2009 Mar; 16(3):311-9. PubMed ID: 19052631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Engineered Capsids for Efficient Gene Delivery to the Retina and Cornea.
    Frederick A; Sullivan J; Liu L; Adamowicz M; Lukason M; Raymer J; Luo Z; Jin X; Rao KN; O'Riordan C
    Hum Gene Ther; 2020 Jul; 31(13-14):756-774. PubMed ID: 32578442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Next-generation AAV vectors-do not judge a virus (only) by its cover.
    Domenger C; Grimm D
    Hum Mol Genet; 2019 Oct; 28(R1):R3-R14. PubMed ID: 31261383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.
    Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N
    J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.
    Shayakhmetov DM; Carlson CA; Stecher H; Li Q; Stamatoyannopoulos G; Lieber A
    J Virol; 2002 Feb; 76(3):1135-43. PubMed ID: 11773389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Site-Specific Post-translational Surface Modification of Adeno-Associated Virus Vectors Using Leucine Zippers.
    Thadani NN; Yang J; Moyo B; Lee CM; Chen MY; Bao G; Suh J
    ACS Synth Biol; 2020 Mar; 9(3):461-467. PubMed ID: 32068391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
    Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
    J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adeno-associated virus vector as a platform for gene therapy delivery.
    Wang D; Tai PWL; Gao G
    Nat Rev Drug Discov; 2019 May; 18(5):358-378. PubMed ID: 30710128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity.
    Paulk NK; Pekrun K; Zhu E; Nygaard S; Li B; Xu J; Chu K; Leborgne C; Dane AP; Haft A; Zhang Y; Zhang F; Morton C; Valentine MB; Davidoff AM; Nathwani AC; Mingozzi F; Grompe M; Alexander IE; Lisowski L; Kay MA
    Mol Ther; 2018 Jan; 26(1):289-303. PubMed ID: 29055620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adeno-associated Virus as a Mammalian DNA Vector.
    Salganik M; Hirsch ML; Samulski RJ
    Microbiol Spectr; 2015 Aug; 3(4):. PubMed ID: 26350320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
    Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells.
    White AF; Mazur M; Sorscher EJ; Zinn KR; Ponnazhagan S
    Hum Gene Ther; 2008 Dec; 19(12):1407-14. PubMed ID: 18778196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bat adeno-associated viruses as gene therapy vectors with the potential to evade human neutralizing antibodies.
    Li Y; Li J; Liu Y; Shi Z; Liu H; Wei Y; Yang L
    Gene Ther; 2019 Jun; 26(6):264-276. PubMed ID: 31110296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modification and labeling of AAV vector particles.
    Büning H; Bolyard CM; Hallek M; Bartlett JS
    Methods Mol Biol; 2011; 807():273-300. PubMed ID: 22034035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.